Neuroscience
Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, Tschanz JT, Mayer LS, Welsh-Bohmer KA, & Breitner JC. Antihypertensive Medication Use and Incident Alzheimer Disease: The Cache County Study. Archives of Neurology; 2006 Mar 13. [Epub ahead of print]
Author Affiliations: Khachaturian and Associates, Inc, Potomac, Md.
BACKGROUND: Recent reports suggest that antihypertensive (AH) medications may reduce the risk of dementing illnesses. OBJECTIVE: To examine the relationship of AH medication use with incidence of Alzheimer disease (AD) among the elderly population (aged 65 years and older) of Cache County, Utah, and to examine whether the relationship varies with different classes of AH medications. METHODS: After an initial (wave 1) multistage assessment (1995 through 1997) to identify prevalent cases of dementia, we used similar methods 3 years later (wave 2) to identify 104 incident cases of AD among the 3308 survivors. At the baseline assessment, we obtained a detailed drug inventory from the study participants. We carried out discrete time survival analyses to examine the association between the use of AH medications (including angiotensin converting enzyme inhibitors, beta-blockers, calcium channel blockers, and diuretics) at baseline with subsequent risk of AD. RESULTS: Use of any AH medication at baseline was associated with lower incidence of AD (adjusted hazard ratio, 0.64; 95% confidence interval, 0.41-0.98). Examination of medication subclasses showed that use of diuretics (adjusted hazard ratio, 0.57; 95% confidence interval, 0.33-0.94), and specifically potassium-sparing diuretics (adjusted hazard ratio, 0.26; 95% confidence interval, 0.08-0.64), was associated with the greatest reduction in risk of AD. Corresponding analysis with a fully examined subsample controlling for blood pressure measurements did not substantially change our findings. CONCLUSIONS: These data suggest that AH medications, and specifically potassium-sparing diuretics, are associated with reduced incidence of AD. Because the latter association is a new finding, it requires confirmation in further study.Published online March 13, 2006 (doi:10.1001/archneur.63.5.noc60013).
PMID: 16533956 [PubMed - as supplied by publisher]
-
Anthony H. Risser | neuroscience | neuropsychology | brain
- Neuropsychology Abstract Of The Day: Aging
Physical Activity and Risk of Cognitive Impairment Among Oldest-Old Women. American Journal of Geriatric Psychiatry. 2013 Jul 3; Wang S, Luo X, Barnes D, Sano M, & Yaffe K.AbstractOBJECTIVES: Physical activity may reduce the risk of cognitive decline...
- Neuropsychology Abstract Of The Day: "cognitive And Behavioural Predictors Of Survival In Alzheimer Disease"
Cognitive and behavioural predictors of survival in Alzheimer disease: Results from a sample of treated patients in a tertiary-referral memory clinic Int J Geriatr Psychiatry. 2011 Sep 29; Russ TC, Batty GD, Starr JM Abstract OBJECTIVE: This study examined...
- Neuropsychology Abstract Of The Day
Tinetti ME, McAvay GJ, Fried TR, Allore HG, Salmon JC, Foody JM, Bianco L, Ginter S, & Fraenkel L. Health outcome priorities among competing cardiovascular, fall injury, and medication-related symptom outcomes. Journal of the American Geriatrics Society....
- Abstract Of The Day: Alzheimer Disease
Pavlik VN, Doody RS, Massman PJ, & Chan W. (2006). Influence of premorbid IQ and education on progression of Alzheimer's Disease. Dementia, Geriatrics, & Cognitive Disorders,22(4), 367-377. [Epub ahead of print] Department of Family and Community...
- Donepezil, Vitamin E, And Mild Cognitive Impairment In Aging
The New England Journal of Medicine has made available on its website prepublication versions of the results of a large study relevant to aging, neuropsychological changes in aging, and the onset of dementia. It has also made available in the same format...
Neuroscience
Abstract of the Day: Antihypertensive Medications and Alzheimer Disease
Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, Tschanz JT, Mayer LS, Welsh-Bohmer KA, & Breitner JC. Antihypertensive Medication Use and Incident Alzheimer Disease: The Cache County Study. Archives of Neurology; 2006 Mar 13. [Epub ahead of print]
Author Affiliations: Khachaturian and Associates, Inc, Potomac, Md.
BACKGROUND: Recent reports suggest that antihypertensive (AH) medications may reduce the risk of dementing illnesses. OBJECTIVE: To examine the relationship of AH medication use with incidence of Alzheimer disease (AD) among the elderly population (aged 65 years and older) of Cache County, Utah, and to examine whether the relationship varies with different classes of AH medications. METHODS: After an initial (wave 1) multistage assessment (1995 through 1997) to identify prevalent cases of dementia, we used similar methods 3 years later (wave 2) to identify 104 incident cases of AD among the 3308 survivors. At the baseline assessment, we obtained a detailed drug inventory from the study participants. We carried out discrete time survival analyses to examine the association between the use of AH medications (including angiotensin converting enzyme inhibitors, beta-blockers, calcium channel blockers, and diuretics) at baseline with subsequent risk of AD. RESULTS: Use of any AH medication at baseline was associated with lower incidence of AD (adjusted hazard ratio, 0.64; 95% confidence interval, 0.41-0.98). Examination of medication subclasses showed that use of diuretics (adjusted hazard ratio, 0.57; 95% confidence interval, 0.33-0.94), and specifically potassium-sparing diuretics (adjusted hazard ratio, 0.26; 95% confidence interval, 0.08-0.64), was associated with the greatest reduction in risk of AD. Corresponding analysis with a fully examined subsample controlling for blood pressure measurements did not substantially change our findings. CONCLUSIONS: These data suggest that AH medications, and specifically potassium-sparing diuretics, are associated with reduced incidence of AD. Because the latter association is a new finding, it requires confirmation in further study.Published online March 13, 2006 (doi:10.1001/archneur.63.5.noc60013).
PMID: 16533956 [PubMed - as supplied by publisher]
-
Anthony H. Risser | neuroscience | neuropsychology | brain
- Neuropsychology Abstract Of The Day: Aging
Physical Activity and Risk of Cognitive Impairment Among Oldest-Old Women. American Journal of Geriatric Psychiatry. 2013 Jul 3; Wang S, Luo X, Barnes D, Sano M, & Yaffe K.AbstractOBJECTIVES: Physical activity may reduce the risk of cognitive decline...
- Neuropsychology Abstract Of The Day: "cognitive And Behavioural Predictors Of Survival In Alzheimer Disease"
Cognitive and behavioural predictors of survival in Alzheimer disease: Results from a sample of treated patients in a tertiary-referral memory clinic Int J Geriatr Psychiatry. 2011 Sep 29; Russ TC, Batty GD, Starr JM Abstract OBJECTIVE: This study examined...
- Neuropsychology Abstract Of The Day
Tinetti ME, McAvay GJ, Fried TR, Allore HG, Salmon JC, Foody JM, Bianco L, Ginter S, & Fraenkel L. Health outcome priorities among competing cardiovascular, fall injury, and medication-related symptom outcomes. Journal of the American Geriatrics Society....
- Abstract Of The Day: Alzheimer Disease
Pavlik VN, Doody RS, Massman PJ, & Chan W. (2006). Influence of premorbid IQ and education on progression of Alzheimer's Disease. Dementia, Geriatrics, & Cognitive Disorders,22(4), 367-377. [Epub ahead of print] Department of Family and Community...
- Donepezil, Vitamin E, And Mild Cognitive Impairment In Aging
The New England Journal of Medicine has made available on its website prepublication versions of the results of a large study relevant to aging, neuropsychological changes in aging, and the onset of dementia. It has also made available in the same format...